Hualan Biological Vaccine Inc.

Founded in 1992, Hualan Bio is a national high-tech enterprise which engages in the production, R&D and marketing of plasma products, vaccines, and antibodies, one of the largest manufacturing enterprises of plasma products and vaccines in China. Hualan Bio owns 25 plasma collection stations in China, with steady and enough plasma supply. Hualan Bio’s property is throughout Henan, Chongqing, Beijing and other 6 provinces and cities, and owns 30 subsidiaries. The influenza vaccine had passed GMP of Ukraine, Cote d'Ivoire, WHO-PQ. The plasma products had been exported to India, Peru, Salvador, Paraguay, Pakistan, Belarus, etc. While the vaccines had been exported to Ukraine, Moldova, Albania, Laos, Morocco, Cote d'Ivoire, Mongolia, UNICEF, etc. Shengming Bio is wholly owned subsidiary of Hualan Group and can provide CRO and CMO services related to monoclonal antibody drugs that fully meet the requirements of CFDA/FDA. The contents of services include screening monoclonal antibody, inspection and testing, evaluation, process R&D, drug analysis, preparation development, production approval application, filling and packaging, labeling, etc.